Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed (2022 - 2025)

Zentalis Pharmaceuticals (ZNTL) has 1 years of Return on Capital Employed data on record, last reported at 0.49% in Q4 2024.

  • For Q4 2024, Return on Capital Employed changed N/A year-over-year to 0.49%; the TTM value through Dec 2024 reached 0.49%, changed N/A, while the annual FY2024 figure was 0.44%, N/A changed from the prior year.
  • Return on Capital Employed reached 0.49% in Q4 2024 per ZNTL's latest filing, up from 0.5% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.49% in Q4 2024 and bottomed at 0.5% in Q3 2024.